Abbott Laboratories (ABT) News Headlines

▮ More

Date

Headline

1/26/2023 9:25:06 AM Abbott Says FDA Oks Proclaim XR Spinal Cord Stimulation System To Treat DPN

1/26/2023 9:01:55 AM FDA Okays Abbott's Spinal Cord Stimulation For People Living With Painful Diabetic Peripheral Neuropathy

1/25/2023 8:01:20 AM Abbott Issues FY23 Earnings, Sales Growth View - Update

1/25/2023 7:37:18 AM Abbott Laboratories Q4 Profit Decreases, but beats estimates

1/25/2023 7:31:26 AM Abbott Q4 GAAP EPS $3.91; Adj EPS $5.34

1/25/2023 6:00:13 AM Abbott Laboratories Q4 22 Earnings Conference Call At 9:00 AM ET

1/21/2023 11:29:01 AM Abbott Reportedly Under Criminal Probe Over Baby Formula

1/17/2023 9:19:04 AM Abbott Says FDA Oks Navitor TAVI System To Treat Severe Aortic Stenosis

1/17/2023 9:01:19 AM Abbott Gets FDA Approval For Navitor, TAVI System Designed To Treat Aortic Stenosis

1/10/2023 11:00:11 AM Abbott Laboratories To Present At J.P. Morgan Healthcare Conference; Webcast At 12:00 PM ET

1/6/2023 10:50:38 PM Abbott, Blood Centers Of America Launch Mixed Reality Experience For Use During Blood Donation

12/21/2022 9:56:35 AM Abbott : FreeStyle Libre 3 Integrated With Automated Insulin Delivery System Mylife Loop In Germany

12/21/2022 9:02:59 AM Abbott Says FreeStyle Libre 3 Integrated With Automated Insulin Delivery System Mylife Loop In Germany

12/19/2022 9:20:40 AM Abbott Says FDA Approves Eterna Spinal Cord Stimulation System To Treat Chronic Pain

12/19/2022 9:03:24 AM FDA) Approves Abbott's Eterna Spinal Cord Stimulation System For Treatment Of Chronic Pain

12/9/2022 11:45:16 AM Abbott Declares Quarterly Dividend Of $0.51/share, Payable Feb. 15/ Record Jan. 13

12/9/2022 11:24:54 AM Abbott Laboratories (ABT) Declares Quarterly Dividend of $ 0.51, Record Date 1/13/2023

10/19/2022 10:13:19 AM Abbott Declines Despite Profit Beating Street

10/19/2022 8:00:31 AM Abbott Laboratories Boosts FY22 Outlook - Update

10/19/2022 7:35:58 AM Abbott Laboratories Q3 Profit Decreases, but beats estimates